Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma

Laboratory Investigation

Volumn 79, Issue 6, 1999, Pages 639-646

  Schmidt, P Henry ^a   Lee, Jeffrey R ^a   Joshi, Viren ^a   Playford, Raymond J ^d   Poulsom, Richard ^b   Wright, Nicholas A ^b,c   Goldenring, James R ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL LINEAGE; DISEASE ASSOCIATION; DYSPLASIA; EXPERIMENTAL INFECTION; HELICOBACTER FELIS; HISTOPATHOLOGY; IMMUNOREACTIVITY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH BIOPSY;

ADENOCARCINOMA; ANIMALS; BIOPSY; GASTRIC FUNDUS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERPLASIA; METAPLASIA; MICE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033052864     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ahnen DJ, Poulsom R, Stamp GWH, Elia G, Pike C, Jeffery R, Longcroft J, Rio M, Chambon P, and Wright NA (1994). The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol 173:317-326.
2. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, and Wright NA (1995). Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 175: 405-414.
3. Babyatsky MW, DeBeaumont M, Thim L, and Podolsky DK (1996). Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 110:489-497.
4. Beck S, Schmitt H, Shizuya H, Blin N, and Gott P (1996). Cloning of contiguous genomic fragments from human chromosome 21 harbouring three trefoil peptide genes. Hum Genet 98:233-235.
5. Bluth RF, Carpenter HA, Pittelkow MR, Page DL, and Coffey RJ (1995). Immunolocalization of transforming growth factor-alpha in normal and diseased human gastric mucosa. Hum Pathol 26:1333-1340.
6. Correa P (1988). A human model of gastric carcinogenesis. Cancer Res 48:3554-3560.
7. Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD, Ahlquist DA, Pittlekow MR, Lee DC, Sandgren EP, Page DL, and Coffey RJ (1992). Possible role of TGFa in the pathogenesis of Menetrier's disease: Supportive evidence from humans and transgenic mice. Gastroenterology 103:1950-1963.
8. Dixon MF, Genta RM, Yardley JH, and Correa P (1996). Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol 20:1161-1181.
9. Elia G, Chinery R, Hanby AM, Poulsom R, and Wright NA (1994). The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochem J 26:644-647.
10. Filipe Ml, Munoz N, Matko I, Kato I, Pompe-Kirn V, Juersek A, Teuchmann S, Benz M, and Prijon T (1994). Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia, Int J Cancer 57:324-329.
11. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacy AR, Wald N, and Sitas F (1991). Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from prospective investigation. Br J Med 302:1302-1305.
12. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, and Wang TC (1996). Hypertrophic gastropathy in Helicobacter felis-infected wild type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 110:155-166.
13. Gott P, Beck S, Machado JC, Carniero F, Schmitt H, and Blin N (1996). Human trefoil peptides: Genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet 4:308-315.
14. Haggitt RC (1994). Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25:982-993.
15. Lee A, Fox JG, Otto G, and Murphy J (1990). A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 99:1315-1323.
16. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, and Rio MC (1996). Gastric mucosa abnormalities and tumorigenesis in mice lacking pS2 trefoil protein. Science 274:259-262.
17. McKenzie C, Marchbank T, Playford RJ, Otto W, Thim L, and Parsons ME (1997). Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility. Am J Physiol 273:G112-G117.
18. Miros M, Kerlin P, and Walker N (1991). Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 32:1441-1446.
19. Mobley HTL (1997). Helicobacter pylori factors associated with disease development. Gastroenterology 113:S21-S28.
20. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez GI, Blaser MJ (1991). Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New Engl J Med 325:1132-1136.
21. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, and Sibley RK (1991). Helicobacter pylori infection and the risk of gastric cancer. New Engl J Med 325:1127-1131.
22. Peura DA (1997). The report of the Digestive Health Initiative international update conference on Helicobacter pylori. Gastroenterology 113:S4-S8.
23. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, DeBeaumont M, Sands BE, and Mahida YR (1993). Identification of human intestinal trefoil factor: Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268:6694-6702.
24. Poulsom R, Hanby AM, Lalani E, Hauser F, Hoffmann W, and Stamp GWH (1997). Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol 183:30-38.
25. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, and Rabinovitch PS (1992). Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 102: 1212-1219.
26. Robertson CS, Mayberry JF, Nicholson DA, James PD, and Atkinson M (1988). Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 75:760-763.
27. Tanaka S, Podolsky DK, Engel E, Guth PH, and Kaunitz JD (1997). Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol 272:G1473-G1480.
28. Thim L (1989). A new family of growth factor-like peptides: "Trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP) and frog skin peptides (spasmolysins). FEBS Lett 250:85-90.
29. 2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 114:675-689.
30. Whitehead R (1989). Gastrointestinal and oesophageal pathology. Edinburgh: Churchill Lingstone, 411.
31. Wright NA, Pike C, and Elia G (1990). Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343: 82-85.